And low price on the spodumene is because they are encountering early contact ore from the mine expansion which is what caused the 3.9% grade in the previous quarter.
Things will arrow with MT Marion once they have 'finished moving a mountain for the expansion' , as Chris has said.
Production surprises should be to the upside from now on IMHO.
- Forums
- ASX - By Stock
- MIN
- Ann: FY23 Q4 Quarterly Activities Report
Ann: FY23 Q4 Quarterly Activities Report, page-17
Featured News
Add MIN (ASX) to my watchlist
(20min delay)
|
|||||
Last
$33.53 |
Change
-1.780(5.04%) |
Mkt cap ! $6.589B |
Open | High | Low | Value | Volume |
$34.62 | $34.99 | $33.36 | $99.83M | 2.953M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 238 | $33.52 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$33.61 | 1000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 238 | 33.520 |
2 | 349 | 33.500 |
2 | 3825 | 33.440 |
1 | 789 | 33.430 |
2 | 160 | 33.420 |
Price($) | Vol. | No. |
---|---|---|
33.610 | 1000 | 1 |
33.700 | 1500 | 1 |
33.750 | 200 | 1 |
33.790 | 1000 | 1 |
33.870 | 1000 | 1 |
Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
Featured News
MIN (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online